Common Biomarkers of Endothelial Dysfunction Across Highly Prevalent Diseases with Cardiovascular Risk: Functional Characterization and Prognostic Implications
Authors:
- Julia Martinez-SanchezJMJulia Martinez-Sanchez
- Sergi Torramadé-MoixSTSergi Torramadé-Moix
- Ana Belén Moreno-CastañoAMAna Belén Moreno-Castaño
- Erica LafozELErica Lafoz
- Jordi RoviraJRJordi Rovira
- Fritz DiekmannFDFritz Diekmann
- Lida Maria RodasLRLida Maria Rodas
- Elena Cuadrado-PayánECElena Cuadrado-Payán
- Isabel GalceranIGIsabel Galceran
- Aleix CasesACAleix Cases
- Ana Paula DantasADAna Paula Dantas
- Joan Albert BarberàJBJoan Albert Barberà
Open Access
- 25 April 2026
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (9) , 3829
Abstract
Endothelial dysfunction (ED) arises in multiple pathologies, and its severity correlates with disease progression. Common ED biomarkers could provide prognostic value for associated complications. This study aims to identify shared ED biomarkers and assess their prognostic significance. Endothelial cells in culture (human microvascular endothelial cells, HMEC-1) were exposed to sera from patients in five disease groups (n = 20 patients/group)—liver cirrhosis with portal hypertension, idiopathic pulmonary arterial hypertension, placental disorders such as intrauterine growth restriction, coronary artery disease with acute myocardial infarction, and chronic kidney disease—or matched controls, in the absence/presence of anti-inflammatory (apixaban) and antioxidant (EUK134) compounds. We explored changes in: VCAM-1, ICAM-1, eNOS, VWF, extracellular matrix thrombogenicity, and reactive oxygen species (ROS). In serum samples, proteomics and metabolomics analyses (including lipids, amino acids, and polar metabolites) were performed through an extraction protocol to identify common ED biomarkers. Expression of VCAM-1, ICAM-1, VWF, platelet adhesion, and ROS increased in most groups versus controls (p < 0.05). Both drugs decreased all biomarker levels except eNOS (n = 6 for in vitro experiments). For serum ED biomarkers, 18 metabolites and 24 proteins showed AUC-ROC and hit rates >77.5%, and six metabolites were associated with event-free survival. These diseases share ED driven by systemic inflammatory, oxidative, and metabolic stress, are partially reversible in vitro, and are linked to biomarkers associated with clinical outcomes. Overall, ED emerges as a modifiable pathological axis with potential prognostic value.Keywords
Funding Information
- Instituto de Salud Carlos III (PIE15/00027)
- Instituto de Salud Carlos III (PI22/00367)
- Instituto de Salud Carlos III (PI22/00240)
- Instituto de Salud Carlos III (PI25/00300)
- Departament de Recerca i Universitats, Generalitat de Catalunya (AGAUR 2021-SGR-01118)
This publication has 60 references indexed in Scilit:
- Modulation function of sphingomyelin molecular species in TLR4 signaling and cell deathCell Reports, 2025
- Endothelial Dysfunction and Therapeutic Advances in Chronic Kidney DiseaseDiabetes/Metabolism Research and Reviews, 2025
- Oxidative stress biomarkers in fetal growth restriction: a systematic review and meta-analysisArchives of Gynecology and Obstetrics, 2025
- Oxidative Stress–Induced Liver Damage and Remodeling of the Liver VasculatureThe American Journal of Pathology, 2023
- Cardiovascular Dysfunction in Intrauterine Growth RestrictionCurrent Hypertension Reports, 2022
- Apixaban Downregulates Endothelial Inflammatory and Prothrombotic Phenotype in an In Vitro Model of Endothelial Dysfunction in UremiaCardiovascular Drugs and Therapy, 2020
- Vascular pathobiology in chronic liver disease and cirrhosis – Current status and future directionsJournal of Hepatology, 2014
- Classification accuracy and cut point selectionStatistics in Medicine, 2012
- Pathogenetic role of eNOS uncoupling in cardiopulmonary disordersFree Radical Biology and Medicine, 2011
- Hepatic endothelial dysfunction and abnormal angiogenesis: New targets in the treatment of portal hypertensionJournal of Hepatology, 2010